BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 −938A>C promoter single nucleotide polymorphism
- 15 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (2) , 874-877
Abstract
High-level BCL2 expression is seen in most patients with chronic lymphocytic leukemia (CLL) in the absence of BCL2 chromosomal translocation. A single nucleotide polymorphism (SNP; −938C>A) within an inhibitory region of the BCL2 promoter has been reported to regulate BCL2 protein expression and to be associated with adverse prognostic features in CLL. We screened 276 patients with CLL for this SNP and 100 patients by quantitative Western blot for BCL2 expression. In contrast to the previous report, we found no association with BCL2 protein levels or with any clinical or laboratory parameters. BCL2 protein levels remained constant in 10 individual patients at different time points. A total of 19 patients with the lowest levels of BCL2 protein expression were biologically and clinically heterogeneous; 5 patients exhibited high-level BCL2 RNA expression and 4 were fludarabine resistant. BCL2 protein levels in CLL reflect a complex interplay of transcriptional and posttranscriptional controls, but do not appear to be associated with the −938C>A promoter SNP.Keywords
This publication has 18 references indexed in Scilit:
- Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2007
- Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737Journal of Clinical Investigation, 2007
- Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNABlood, 2006
- Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemiaBlood, 2006
- Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expressionOncogene, 2005
- miR-15 and miR-16 induce apoptosis by targeting BCL2Proceedings of the National Academy of Sciences of the United States of America, 2005
- An inhibitor of Bcl-2 family proteins induces regression of solid tumoursNature, 2005
- REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1996
- A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter.Molecular and Cellular Biology, 1993
- Establishment and characterization of three new malignant lymphoid cell linesInternational Journal of Cancer, 1987